4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Jiang-Jiang Qin, Sushanta Sarkar, Sukesh Voruganti, Rajesh Agarwal, Wei Wang, Ruiwen Zhang. Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy[J]. The Journal of Biomedical Research, 2016, 30(4): 322-333. DOI: 10.7555/JBR.30.20160018
Citation: Jiang-Jiang Qin, Sushanta Sarkar, Sukesh Voruganti, Rajesh Agarwal, Wei Wang, Ruiwen Zhang. Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy[J]. The Journal of Biomedical Research, 2016, 30(4): 322-333. DOI: 10.7555/JBR.30.20160018

Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy

Funds: 

the National Institutes of Health (NIH) grant R01 CA186662 (to R.Z.) , CA102514 (to R.A.),and American Cancer Society (ACS) grant RSG-15-009-01-CDD (to W.W.)

More Information
  • Received Date: January 28, 2016
  • Revised Date: February 21, 2016
  • There is an increasing interest in development of novel anticancer agents that target oncogenes. We have recently discovered that nuclear factor of activated T cells 1 (NFAT1) is a novel regulator of the Mouse Double Minute 2 (MDM2) oncogene and the NFAT1-MDM2 pathway has been implicated in human cancer development and progression, justifying that targeting the NFAT1-MDM2 pathway could be a novel strategy for discovery and development of novel cancer therapeutics. The present study was designed to examine the anticancer activity and underlying mechanisms of action of lineariifolianoid A (LinA), a novel natural product inhibitor of the NFAT1-MDM2 pathway. The cytotoxicity of LinA was first tested in various human cancer cell lines in comparison with normal cell lines. The results showed that the breast cancer cells were highly sensitive to LinA treatment. We next demonstrated the effects of LinA on cell proliferation, colony formation, cell cycle progression, and apoptosis in breast cancer MCF7 and MDA-MB-231 cells, in dose-dependent and p53-independent manners. LinA also inhibited the migration and invasion of these cancer cells. Our mechanistic studies further indicated that its anticancer activities were attributed to its inhibitory effects on the NFAT1-MDM2 pathway and modulatory effects on the expression of key proteins involved in cell cycle progression, apoptosis, and DNA damage. In summary, LinA is a novel NFAT1-MDM2 inhibitor and may be developed as a preventive and therapeutic agent against human cancer.
  • Related Articles

    [1]Izzatullo Ziyoyiddin o`g`li Abdullaev, Ulugbek Gapparjanovich Gayibov, Sirojiddin Zoirovich Omonturdiev, Sobirova Fotima Azamjonovna, Sabina Narimanovna Gayibova, Takhir Fatikhovich Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240387
    [2]Zhaoye Qian, Zhe Zhang, Lanqi Cen, Yaohua Ke, Jie Shao, Manman Tian, Baorui Liu. Mycobacterium smegmatis enhances shikonin-induced immunogenic cell death—an efficient in situ tumor vaccine strategy[J]. The Journal of Biomedical Research, 2024, 38(4): 369-381. DOI: 10.7555/JBR.38.20240049
    [3]Cui Qi, Jiaqi Zhang, Yuanyuan Wang, Mingyan Lin, Jun Gao, Haiying Lu. Valproic acid enhances neurosphere formation in cultured rat embryonic cortical cells through TGFβ1 signaling[J]. The Journal of Biomedical Research, 2022, 36(2): 127-140. DOI: 10.7555/JBR.36.20210109
    [4]Xu Wenbin, Yan Han, Xu Lulu, Li Mingna, Gao Wentao, Jiang Kuirong, Wu Junli, Miao Yi. Correlation between radiologic features on contrast-enhanced CT and pathological tumor grades in pancreatic neuroendocrine neoplasms[J]. The Journal of Biomedical Research, 2021, 35(3): 179-188. DOI: 10.7555/JBR.34.20200039
    [5]Yang Lukun, Tautz Timothy, Zhang Shulin, Fomina Alla, Liu Hong. The current status of malignant hyperthermia[J]. The Journal of Biomedical Research, 2020, 34(2): 75-85. DOI: 10.7555/JBR.33.20180089
    [6]Huanqiang Wang, Congying Yang, Siyuan Wang, Tian Wang, Jingling Han, Kai Wei, Fucun Liu, Jida Xu, Xianzhen Peng, Jianming Wang. Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer[J]. The Journal of Biomedical Research, 2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065
    [7]Cuiying Li, Haiyan Gong, Lijun Ling, Liwen Du, Tong Su, Shui Wang, Jie Wang. Diagnostic performance of contrast-enhanced ultrasound and enhanced magnetic resonance for breast nodules[J]. The Journal of Biomedical Research, 2018, 32(3): 198-207. DOI: 10.7555/JBR.32.20180015
    [8]Nolan B. Ayers, Chenming Sun, Shi-You Chen. Transforming growth factor-β signaling in systemic sclerosis[J]. The Journal of Biomedical Research, 2018, 32(1): 3-12. DOI: 10.7555/JBR.31.20170034
    [9]Jun Han, Chuanbing Shi, Xiaogang Dong, Jie Wang, Hao Wen, Baolin Wang, Zhenyu He. Laparoscopic abdomino-perineal resection for patients with anorectal malignant melanoma: a report of 4 cases[J]. The Journal of Biomedical Research, 2016, 30(5): 436-440. DOI: 10.7555/JBR.27.20120099
    [10]Subhasree Nag, Jiangjiang Qin, Kalkunte S. Srivenugopal, Minghai Wang, Ruiwen Zhang. The MDM2-p53 pathway revisited[J]. The Journal of Biomedical Research, 2013, 27(4): 254-271. DOI: 10.7555/JBR.27.20130030
  • Cited by

    Periodical cited type(1)

    1. Gawel AM, Betkowska A, Gajda E, et al. Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment. Biomedicines, 2024, 12(8): 1822. DOI:10.3390/biomedicines12081822

    Other cited types(0)

Catalog

    Article Metrics

    Article views PDF downloads Cited by(1)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return